Thirteen primary and three metastatic tumors harbored KRAS mutations: c.35G>A (6/16), c.35G>T (5/16), c.34G>T (3/16), c.53G>C (1/16), and c.37G>T (1/16). Here, KRAS is linked to metastatic neoplasm.